Travere Therapeutics Inc
NASDAQ:TVTX
Income Statement
Earnings Waterfall
Travere Therapeutics Inc
Revenue
|
145.2m
USD
|
Cost of Revenue
|
-11.5m
USD
|
Gross Profit
|
133.8m
USD
|
Operating Expenses
|
-510.5m
USD
|
Operating Income
|
-376.7m
USD
|
Other Expenses
|
265.3m
USD
|
Net Income
|
-111.4m
USD
|
Income Statement
Travere Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
6
+19 133%
|
14
+145%
|
28
+100%
|
46
+61%
|
64
+40%
|
84
+31%
|
100
+20%
|
112
+12%
|
121
+8%
|
127
+5%
|
134
+5%
|
138
+3%
|
144
+4%
|
150
+4%
|
155
+3%
|
160
+3%
|
162
+2%
|
163
+0%
|
164
+1%
|
165
+1%
|
169
+2%
|
172
+2%
|
175
+2%
|
184
+5%
|
187
+2%
|
194
+4%
|
198
+2%
|
198
0%
|
204
+3%
|
221
+8%
|
228
+3%
|
229
+0%
|
178
-22%
|
137
-23%
|
212
+54%
|
145
-32%
|
147
+2%
|
156
+6%
|
145
-7%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(5)
|
(8)
|
(8)
|
(8)
|
(9)
|
(11)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
6
+19 033%
|
14
+142%
|
28
+99%
|
45
+62%
|
62
+40%
|
82
+31%
|
98
+19%
|
109
+11%
|
118
+8%
|
123
+4%
|
129
+5%
|
134
+4%
|
139
+4%
|
146
+5%
|
151
+3%
|
155
+3%
|
157
+1%
|
158
+0%
|
159
+1%
|
160
+1%
|
164
+2%
|
167
+2%
|
170
+2%
|
178
+5%
|
181
+2%
|
188
+4%
|
192
+2%
|
192
0%
|
198
+3%
|
214
+8%
|
221
+3%
|
221
+0%
|
172
-22%
|
132
-23%
|
204
+55%
|
136
-33%
|
139
+2%
|
147
+6%
|
134
-9%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(25)
|
(45)
|
(62)
|
(87)
|
(107)
|
(111)
|
(118)
|
(132)
|
(144)
|
(151)
|
(168)
|
(173)
|
(182)
|
(198)
|
(206)
|
(202)
|
(199)
|
(213)
|
(223)
|
(246)
|
(239)
|
(253)
|
(272)
|
(259)
|
(285)
|
(277)
|
(267)
|
(274)
|
(271)
|
(400)
|
(418)
|
(447)
|
(383)
|
(402)
|
(401)
|
(412)
|
(471)
|
(457)
|
(489)
|
(508)
|
(511)
|
|
Selling, General & Administrative |
(18)
|
(31)
|
(35)
|
(47)
|
(60)
|
(57)
|
(65)
|
(68)
|
(67)
|
(69)
|
(72)
|
(74)
|
(77)
|
(81)
|
(86)
|
(87)
|
(84)
|
(90)
|
(86)
|
(87)
|
(87)
|
(92)
|
(106)
|
(109)
|
(110)
|
(110)
|
(106)
|
(107)
|
(115)
|
(117)
|
(117)
|
(120)
|
(126)
|
(136)
|
(148)
|
(167)
|
(196)
|
(213)
|
(228)
|
(238)
|
(237)
|
|
Research & Development |
(7)
|
(14)
|
(26)
|
(37)
|
(48)
|
(50)
|
(47)
|
(49)
|
(50)
|
(54)
|
(61)
|
(66)
|
(71)
|
(77)
|
(79)
|
(80)
|
(78)
|
(83)
|
(98)
|
(111)
|
(123)
|
(131)
|
(135)
|
(135)
|
(140)
|
(137)
|
(129)
|
(129)
|
(131)
|
(148)
|
(169)
|
(185)
|
(209)
|
(218)
|
(220)
|
(227)
|
(230)
|
(224)
|
(233)
|
(236)
|
(238)
|
|
Depreciation & Amortization |
0
|
0
|
(2)
|
(3)
|
0
|
0
|
(6)
|
(8)
|
(13)
|
(15)
|
(15)
|
(16)
|
(16)
|
(16)
|
(17)
|
(17)
|
(17)
|
(17)
|
(18)
|
(18)
|
(18)
|
(19)
|
(19)
|
(19)
|
(20)
|
(20)
|
(21)
|
(22)
|
(22)
|
(23)
|
(24)
|
(24)
|
(25)
|
(26)
|
(21)
|
(19)
|
(31)
|
(24)
|
(30)
|
(36)
|
(36)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(3)
|
(0)
|
(7)
|
(14)
|
(12)
|
(19)
|
(18)
|
(18)
|
(24)
|
(25)
|
(19)
|
(19)
|
(22)
|
(21)
|
(31)
|
(12)
|
(11)
|
(12)
|
5
|
(15)
|
(10)
|
(11)
|
(17)
|
(4)
|
(111)
|
(109)
|
(117)
|
(22)
|
(23)
|
(12)
|
0
|
(15)
|
5
|
2
|
2
|
0
|
|
Operating Income |
(25)
N/A
|
(45)
-80%
|
(57)
-27%
|
(73)
-30%
|
(80)
-9%
|
(66)
+17%
|
(56)
+16%
|
(50)
+11%
|
(46)
+8%
|
(42)
+9%
|
(51)
-21%
|
(50)
+1%
|
(53)
-6%
|
(64)
-21%
|
(67)
-3%
|
(56)
+16%
|
(48)
+15%
|
(57)
-20%
|
(65)
-14%
|
(89)
-36%
|
(80)
+9%
|
(93)
-16%
|
(108)
-16%
|
(92)
+15%
|
(115)
-25%
|
(99)
+14%
|
(86)
+14%
|
(86)
N/A
|
(79)
+8%
|
(209)
-164%
|
(221)
-6%
|
(233)
-6%
|
(162)
+31%
|
(180)
-11%
|
(229)
-27%
|
(280)
-22%
|
(267)
+5%
|
(321)
-20%
|
(351)
-9%
|
(361)
-3%
|
(377)
-4%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(10)
|
(61)
|
(35)
|
(25)
|
(34)
|
(22)
|
(80)
|
(54)
|
(42)
|
14
|
37
|
(3)
|
1
|
(12)
|
(5)
|
(3)
|
(6)
|
(7)
|
(5)
|
2
|
(4)
|
(6)
|
(8)
|
(9)
|
(9)
|
(10)
|
(11)
|
(12)
|
(14)
|
(16)
|
(17)
|
(17)
|
(18)
|
(15)
|
(14)
|
(10)
|
(5)
|
(2)
|
3
|
6
|
10
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
13
|
4
|
7
|
0
|
(9)
|
(5)
|
(5)
|
0
|
0
|
(1)
|
(6)
|
0
|
0
|
(19)
|
(17)
|
(25)
|
(25)
|
(23)
|
(23)
|
(15)
|
(15)
|
0
|
(97)
|
0
|
0
|
0
|
0
|
(8)
|
(8)
|
(8)
|
(8)
|
0
|
0
|
0
|
(11)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
140
|
140
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
1
|
0
|
49
|
49
|
49
|
47
|
140
|
139
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
0
|
1
|
2
|
|
Pre-Tax Income |
(35)
N/A
|
(105)
-205%
|
(91)
+14%
|
(98)
-8%
|
(113)
-15%
|
(38)
+66%
|
(73)
-91%
|
89
N/A
|
106
+18%
|
112
+6%
|
117
+4%
|
(58)
N/A
|
(58)
+1%
|
(77)
-33%
|
(71)
+7%
|
(60)
+16%
|
(58)
+2%
|
(63)
-8%
|
(70)
-11%
|
(105)
-50%
|
(102)
+3%
|
(124)
-22%
|
(141)
-13%
|
(124)
+12%
|
(146)
-18%
|
(124)
+15%
|
(111)
+10%
|
(97)
+13%
|
(189)
-95%
|
(224)
-19%
|
(237)
-6%
|
(250)
-6%
|
(180)
+28%
|
(202)
-12%
|
(249)
-23%
|
(297)
-19%
|
(278)
+6%
|
(322)
-16%
|
(348)
-8%
|
(353)
-2%
|
(376)
-6%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
2
|
2
|
3
|
43
|
40
|
1
|
12
|
(23)
|
(16)
|
17
|
10
|
7
|
1
|
9
|
(0)
|
(3)
|
(5)
|
(6)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(35)
|
(106)
|
(89)
|
(96)
|
(111)
|
4
|
(33)
|
90
|
117
|
89
|
101
|
(42)
|
(48)
|
(70)
|
(70)
|
(51)
|
(59)
|
(66)
|
(75)
|
(112)
|
(103)
|
(125)
|
(142)
|
(124)
|
(146)
|
(124)
|
(111)
|
(97)
|
(189)
|
(224)
|
(238)
|
(251)
|
(180)
|
(202)
|
(249)
|
(297)
|
(279)
|
(322)
|
(348)
|
(354)
|
(376)
|
|
Net Income (Common) |
(35)
N/A
|
(106)
-205%
|
(89)
+16%
|
(96)
-8%
|
(111)
-16%
|
4
N/A
|
(33)
N/A
|
90
N/A
|
117
+30%
|
89
-24%
|
101
+14%
|
(42)
N/A
|
(48)
-15%
|
(70)
-47%
|
(70)
+0%
|
(51)
+28%
|
(60)
-18%
|
(67)
-12%
|
(76)
-14%
|
(113)
-48%
|
(103)
+9%
|
(125)
-22%
|
(142)
-13%
|
(124)
+13%
|
(146)
-18%
|
(105)
+29%
|
(92)
+12%
|
(78)
+15%
|
(169)
-117%
|
(224)
-32%
|
(237)
-6%
|
(250)
-6%
|
(180)
+28%
|
(202)
-12%
|
(230)
-14%
|
(264)
-15%
|
(279)
-5%
|
(289)
-4%
|
(307)
-6%
|
(87)
+72%
|
(111)
-28%
|
|
EPS (Diluted) |
-1.87
N/A
|
-4.52
-142%
|
-3.24
+28%
|
-3.59
-11%
|
-4.43
-23%
|
0.13
N/A
|
-0.94
N/A
|
2.11
N/A
|
3.12
+48%
|
2.33
-25%
|
2.75
+18%
|
-1.14
N/A
|
-1.29
-13%
|
-1.84
-43%
|
-1.79
+3%
|
-1.32
+26%
|
-1.53
-16%
|
-1.67
-9%
|
-1.82
-9%
|
-2.77
-52%
|
-2.54
+8%
|
-3.02
-19%
|
-3.37
-12%
|
-2.87
+15%
|
-3.46
-21%
|
-2.42
+30%
|
-2.05
+15%
|
-1.53
+25%
|
-3.56
-133%
|
-3.98
-12%
|
-3.91
+2%
|
-4.11
-5%
|
-3.01
+27%
|
-3.2
-6%
|
-3.53
-10%
|
-4.12
-17%
|
-4.37
-6%
|
-4.23
+3%
|
-3.72
+12%
|
-1.14
+69%
|
-1.49
-31%
|